Factor XIII deficiency: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +) |
||
(One intermediate revision by one other user not shown) | |||
Line 17: | Line 17: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Line 29: | Line 29: | ||
{{Hematology}} | {{Hematology}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Disease]] | |||
[[Category:Hematology]] |
Latest revision as of 02:34, 9 August 2012
For patient information click here
Factor XIII deficiency | |
ICD-10 | D68.2 |
---|---|
ICD-9 | 286.3 |
OMIM | 134570 134580 |
DiseasesDB | 31412 |
MeSH | D005177 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Factor XIII deficiency may occur very rarely, and can cause a severe bleeding tendency. Incidence is 1 in a million to 1 in 5 million people. Most are due to mutations in the A subunit. Administration of recombinant A subunit improves clot stability and may become a therapeutic option for patients with this condition[1].
See also
References
- ↑ Lovejoy A, Reynolds T, Visich J, Butine M, Young G, Belvedere M, Blain R, Pederson S, Ishak L, Nugent D (2006). "Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency". Blood. 108 (1): 57–62. PMID 16556896.